NCT05208944Phase 2Active not recruiting

THIO Sequenced With Cemiplimab in Advanced NSCLC

Study sponsor: Maia Biotechnology

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-09-30Estimated
Enrollment · participants227Estimated
Source updated2026-09-16Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

· 1 field changed

Primary completion date changed

Before: 30 Jun 2026. After: 30 Sep 2027.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview